Is a complete RLYB research report available?

No complete published report is available for Rallybio Corporation (RLYB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Rallybio Corporation (RLYB)

NASDAQ: RLYB · USD

$16.1

+0.11 (+0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RLYB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	85.1M
Revenue (ttm)	858K
Net income (ttm)	-7.8M
EPS (ttm)	-$1.38
Shares out	5.3M
Volume	12,046
Beta	-0.89

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 858K
Net income (ttm): -7.8M
EPS (ttm): -$1.38
Market cap: 85.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RLYB indicators

Market & fundamental data

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739410
Company name	Rallybio Corporation
Country	United States
Country code	US
Cusip	75120L209
Employees	9
Employees Change	-15%
Employees Change Percent	-62.5
Enterprise value	$38.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-29
Isin	US75120L2097
Last refreshed	2026-07-31
Market cap	$85.1M
Market cap category	Micro-Cap
Price	$16.07
Price currency	USD
Rev Per Employee	95,333.33x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	RLYB
Website	https://www.rallybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-9.18%
EV/Sales	44.87x
FCF yield	-32.4%
P/B ratio	1.69x
P/S ratio	99.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3,744.41%
EBITDA Margin	-3,736.6%
Gross Profit	$-14.7M
Net Income	$-7.8M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-911.07%
Profit Per Employee	$-868,556
ROA	-33.04
Roa5y	-28.66
ROCE	-63.83
ROE	-14.98
Roe5y	-41.36
ROIC	-35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	327.64%
Cagr3y	-30.25%
Cagr5y	-32.28%
EPS Growth Quarters	8
EPS Growth Years	3
Revenue Growth	1.18x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$54.5M
Cash	$46.8M
Current Assets	$53.5M
Current Liabilities	$4.1M
Debt	$154,000
Debt Equity	$0
Equity	$50.3M
Liabilities	$4.2M
Long Term Assets	$982,000
Long Term Liabilities	$55,000
Net Cash	$46.6M
Net Cash By Market Cap	$54.78
Net Cash Growth	-14.23%
Net Debt Equity	$-0.93
Tangible Book Value	$50.3M
Tangible Book Value Per Share	$9.5
WACC	-0.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	12.92
Net Working Capital	$2.7M
Quick ratio	11.3
Working Capital	$49.4M
Working Capital Turnover	$0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.5%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	327.21%
200-day SMA	9.24
3Y total return	-66.07%
50-day SMA	15.85
50-day SMA vs 200-day SMA	50over200
5Y total return	-85.75%
All Time High	206.2
All Time High Change	-92.21%
All Time High Date	2021-07-30
All Time Low	1.76
All Time Low Change	812.55%
All Time Low Date	2025-04-08
ATR	0.49
Beta	-0.89
Beta1y	0.41
Beta2y	1.04
Ch YTD	192.8
High	16.28
High52	17.57
High52 Date	2026-06-01
High52ch	-8.56%
Low	15.9
Low52	3.2
Low52 Date	2025-08-12
Low52ch	402.19%
Ma50ch	1.4%
Premarket Change Percent	0.81
Premarket Price	$16.09
Premarket Volume	600
Price vs 200-day SMA	73.99%
RSI	51.47
RSI Monthly	52.62
RSI Weekly	72.3
Sharpe ratio	1.93x
Sortino ratio	4.86
Total Return	-1.5%
Tr YTD	192.8
Tr1m	0.06%
Tr1w	-1.95%
Tr3m	80.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1.28
Operating Income	$-29.7M
Operating margin	-3,464.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	785,190%
Float Percent	14.82%
Shares Insiders	18.93%
Shares Institutions	33.05%
Shares Out	5,298,137
Shares Qo Q	0.1%
Shares Yo Y	1.5%
Short Float	21.67%
Short Ratio	3.22
Short Shares	3.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-31.6M
Adjusted OCF	-31,634,000
Average Volume	41,384.75x
Bv Per Share	9.5
Ch1m	0.06
Ch1w	-1.95
Ch1y	327.2
Ch3m	80.97
Ch3y	-66.07
Ch5y	-85.75
Ch6m	200.8
Change	0.69%
Change From Open	1.01
Close	15.96
Days Gap	-0.31
Depreciation Amortization	67,000
Dollar Volume	193,579.2
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-32.1M
EBITDA	$-32.1M
EPS	$-1.38
F Score	2
FCF	$-27.6M
FCF EV Yield	-71.65x
FCF Per Share	$-5.21
Financing CF	19,000
Fiscal Year End	December
Founded	2,018
Investing CF	54,087,000
Ipr	23.62
Iprfo	-86.54
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2026-02-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	10.58
Ma150ch	51.92%
Ma20	16.12
Ma20ch	-0.28%
Net CF	26,520,000
Next Earnings Date	2026-08-10
Open	15.91
Optionable	No
Position In Range	44.74
Post Close	16.07
Postmarket Change Percent	0
Postmarket Price	$16.07
Ppne	172,000
Pre Close	15.96
Price Date	2026-07-30
Ptbv Ratio	1.69
Relative Volume	0.29x
Revenue	858,000x
SBC By Revenue	471.79x
Share Based Comp	4,048,000
Tr6m	200.76%
Us State	Connecticut
Volume	12,046
Z Score	-5.14

Rallybio Corporation (RLYB)

Coverage state: Market snapshot only — no published research

Generate the first RLYB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · RLYB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RLYB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RLYB

Frequently asked questions